China, US Carve Own Paths But Physicians Urge Collaboration With Vaccines Years Away
Global Health Rivalry Or Partnerships?
Executive Summary
Despite different approaches, top virologists and renowned front-line physicians from China and the US see the need to share clinical experiences and for global cooperation on treatments and vaccines as economies start re-opening amid fear of a second wave.
You may also be interested in...
Coronavirus Update: Rapid Japan Approval For Remdesivir, Combination With Lilly's Olumiant Is Next Hope
Plus: Chugai enters into Singapore research alliance, Korean consortium reports vaccine progress.
China Approves First Coronavirus Drugs, Rushes Two Vaccine Trials
A coronavirus vaccine race is on in China with three domestic developers leading the charge, while traditional medicines are pioneering the drug race after the first official approvals of treatments for COVID-19.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.